Home/Filings/4/0001567619-22-006732
4//SEC Filing

Lubben Terry W. 4

Accession 0001567619-22-006732

CIK 0001630627other

Filed

Mar 9, 7:00 PM ET

Accepted

Mar 10, 8:26 PM ET

Size

9.5 KB

Accession

0001567619-22-006732

Insider Transaction Report

Form 4
Period: 2022-03-08
Lubben Terry W.
SVP, Operations
Transactions
  • Purchase

    Common Stock

    2022-03-08$18.62/sh+2,500$46,5505,850 total
  • Award

    Common Stock

    2022-03-08+3,3503,350 total
  • Award

    Stock Option (Right to Buy)

    2022-03-08+25,80025,800 total
    Exercise: $19.15Exp: 2032-03-08Common Stock (25,800 underlying)
Footnotes (4)
  • [F1]Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs vest in equal annual installments over 4 years, commencing on March 8, 2023 with the last installment on March 8, 2026? subject to Reporting Person's providing continued service to Issuer through each vesting date.
  • [F2]Includes 3,350 RSUs.
  • [F3]The price reported in Column 4 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $18.347 to $18.65 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
  • [F4]The stock option will vest in equal annual installments over 4 years, commencing on March 8, 2023 with the last installment on March 8, 2026; subject to Reporting Person's providing continued service to Issuer through each vesting date.

Documents

1 file

Issuer

TREACE MEDICAL CONCEPTS, INC.

CIK 0001630627

Entity typeother

Related Parties

1
  • filerCIK 0001882643

Filing Metadata

Form type
4
Filed
Mar 9, 7:00 PM ET
Accepted
Mar 10, 8:26 PM ET
Size
9.5 KB